Kryxana 200mg Tablet

Produktübersicht

About Kryxana

Kryxana is a medication containing the active ingredient Ribociclib. Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor. It was developed by Novartis and Astex Pharmaceuticals.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE KISQALI is a kinase inhibitor indicated: in combination with an aromatase inhibitor for the adjuvant treatment of adults with.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Ribociclib, the active ingredient in Kryxana, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE KISQALI is a kinase inhibitor indicated: in combination with an aromatase inhibitor for the adjuvant treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage II and III early breast cancer at high risk of recurrence. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Kryxana. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Kryxana for extended periods without medical advice.